Histone Sample Preparation for Bottom-Up Mass Spectrometry: A Roadmap to Informed Decisions.

GingisREX coverage epigenetics histone code mass spectrometry sample preparation workflow optimization

Journal

Proteomes
ISSN: 2227-7382
Titre abrégé: Proteomes
Pays: Switzerland
ID NLM: 101621966

Informations de publication

Date de publication:
21 Apr 2021
Historique:
received: 26 02 2021
revised: 08 04 2021
accepted: 19 04 2021
entrez: 30 4 2021
pubmed: 1 5 2021
medline: 1 5 2021
Statut: epublish

Résumé

Histone-based chromatin organization enabled eukaryotic genome complexity. This epigenetic control mechanism allowed for the differentiation of stable gene-expression and thus the very existence of multicellular organisms. This existential role in biology makes histones one of the most complexly modified molecules in the biotic world, which makes these key regulators notoriously hard to analyze. We here provide a roadmap to enable fast and informed selection of a bottom-up mass spectrometry sample preparation protocol that matches a specific research question. We therefore propose a two-step assessment procedure: (i) visualization of the coverage that is attained for a given workflow and (ii) direct alignment between runs to assess potential pitfalls at the ion level. To illustrate the applicability, we compare four different sample preparation protocols while adding a new enzyme to the toolbox, i.e., RgpB (GingisREX

Identifiants

pubmed: 33919160
pii: proteomes9020017
doi: 10.3390/proteomes9020017
pmc: PMC8167631
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Fonds Wetenschappelijk Onderzoek
ID : 11B4518N
Organisme : Fonds Wetenschappelijk Onderzoek
ID : 12E9716N
Organisme : Fonds Wetenschappelijk Onderzoek
ID : 3S031319
Organisme : Bijzonder Onderzoeksfonds UGent
ID : 01D22020

Références

Curr Opin Chem Biol. 2016 Aug;33:142-50
pubmed: 27371874
Science. 2001 Aug 10;293(5532):1074-80
pubmed: 11498575
Bioessays. 2015 Jan;37(1):70-9
pubmed: 25350939
Mol Cell Proteomics. 2014 Sep;13(9):2450-66
pubmed: 25000943
Mol Cell Proteomics. 2014 Dec;13(12):3709-15
pubmed: 25106551
Methods Enzymol. 2017;586:359-378
pubmed: 28137571
Nat Protoc. 2007;2(4):933-8
pubmed: 17446892
J Chromatogr. 1991 May 10;543(2):451-61
pubmed: 1652592
J Proteome Res. 2017 Feb 3;16(2):655-664
pubmed: 28152592
Methods Enzymol. 1977;47:165-70
pubmed: 927173
Bioinformatics. 2019 Dec 15;35(24):5243-5248
pubmed: 31077310
Epigenomics. 2012 Apr;4(2):163-77
pubmed: 22449188
Methods. 2020 Dec 1;184:86-92
pubmed: 32070774
J Proteome Res. 2020 Mar 6;19(3):993-999
pubmed: 32068400
Cell. 2012 Jan 20;148(1-2):24-8
pubmed: 22265398
Proteomics. 2014 May;14(10):1130-40
pubmed: 24644084
Proteomics. 2016 Jul;16(14):2059-63
pubmed: 27080621
Proteomics. 2015 Sep;15(17):2966-71
pubmed: 26010583
Int J Mol Sci. 2014 May 27;15(6):9407-21
pubmed: 24871368
Chem Rev. 2015 Mar 25;115(6):2376-418
pubmed: 25688442
J Biol Chem. 1992 Sep 15;267(26):18896-901
pubmed: 1527017
Expert Rev Proteomics. 2017 Jul;14(7):617-626
pubmed: 28649883
Proteomics. 2016 Jul;16(14):1952-4
pubmed: 27373704
Nucleic Acids Res. 2015 Jul 1;43(W1):W566-70
pubmed: 25969447
Proteomics. 2015 Sep;15(17):2901-2
pubmed: 26223514
J Proteome Res. 2019 Nov 1;18(11):3840-3849
pubmed: 31429292
Int J Biochem Cell Biol. 2014 Jun;51:39-44
pubmed: 24685679
PLoS Genet. 2018 Sep 13;14(9):e1007582
pubmed: 30212449
Biol Chem. 2015 Apr;396(4):377-84
pubmed: 25720118
Proteomics. 2015 May;15(9):1459-69
pubmed: 25641854
Biol Chem. 2001 Sep;382(9):1399-404
pubmed: 11688723
Trends Microbiol. 2019 Aug;27(8):703-714
pubmed: 31076245
Proteomics. 2016 Jul;16(14):1970-4
pubmed: 27139031
Proteomics. 2020 Feb;20(3-4):e1900306
pubmed: 31981311
Proteomics. 2011 Jun;11(12):2565-7
pubmed: 21591257
Proteomics. 2014 Mar;14(4-5):489-97
pubmed: 24339419
Nucleic Acids Res. 2019 Jul 2;47(W1):W295-W299
pubmed: 31028400
Nat Struct Biol. 2003 Nov;10(11):882-91
pubmed: 14583738

Auteurs

Simon Daled (S)

Laboratory of Pharmaceutical Biotechnology/ProGenTomics, Ghent University, Ottergemsesteenweg 460, 9000 Ghent, Belgium.

Sander Willems (S)

Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, 82152 Martinsried, Germany.

Bart Van Puyvelde (B)

Laboratory of Pharmaceutical Biotechnology/ProGenTomics, Ghent University, Ottergemsesteenweg 460, 9000 Ghent, Belgium.

Laura Corveleyn (L)

Laboratory of Pharmaceutical Biotechnology/ProGenTomics, Ghent University, Ottergemsesteenweg 460, 9000 Ghent, Belgium.

Sigrid Verhelst (S)

Laboratory of Pharmaceutical Biotechnology/ProGenTomics, Ghent University, Ottergemsesteenweg 460, 9000 Ghent, Belgium.

Laura De Clerck (L)

Laboratory of Pharmaceutical Biotechnology/ProGenTomics, Ghent University, Ottergemsesteenweg 460, 9000 Ghent, Belgium.

Dieter Deforce (D)

Laboratory of Pharmaceutical Biotechnology/ProGenTomics, Ghent University, Ottergemsesteenweg 460, 9000 Ghent, Belgium.

Maarten Dhaenens (M)

Laboratory of Pharmaceutical Biotechnology/ProGenTomics, Ghent University, Ottergemsesteenweg 460, 9000 Ghent, Belgium.

Classifications MeSH